GAMMAGARD S-D

Manufacturer:

Baxalta

Name:

GAMMAGARD S-D

HCPCS Code Descriptor:

Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg

Category:

J Code

HCPCS:

J1566

NDC(s):

00944-2658-04, 00944-2656-03

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

GAMMAGARD S-D is an Immunoglobulin drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J1566 is aligned to the drug GAMMAGARD S-D.

Gammagard S/D is used to help protect people with weakened immune systems by increasing platelet count. Gammagard S/D can also be used to treat certain cases of muscle weakness, certain nerve disorders, and blood vessel disorders. Gammagard S/D is administered as an intravenous injection of human blood that contains a high level of antibodies. Gammagard Liquid, is a different product than Gammagard S/D. Gammagard S/D is mapped to the HCPCS J1566 while Gammagard Liquid is mapped to the HCPCS J1569. The product monograph for Gammagard S/D can be found through Takeda.